vs

Side-by-side financial comparison of Ispire Technology Inc. (ISPR) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $20.3M, roughly 1.6× Ispire Technology Inc.). RxSight, Inc. runs the higher net margin — -28.1% vs -32.5%, a 4.5% gap on every dollar of revenue. On growth, RxSight, Inc. posted the faster year-over-year revenue change (-18.9% vs -51.5%). RxSight, Inc. produced more free cash flow last quarter ($-2.3M vs $-4.0M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -17.8%).

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

ISPR vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.6× larger
RXST
$32.6M
$20.3M
ISPR
Growing faster (revenue YoY)
RXST
RXST
+32.6% gap
RXST
-18.9%
-51.5%
ISPR
Higher net margin
RXST
RXST
4.5% more per $
RXST
-28.1%
-32.5%
ISPR
More free cash flow
RXST
RXST
$1.8M more FCF
RXST
$-2.3M
$-4.0M
ISPR
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-17.8%
ISPR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ISPR
ISPR
RXST
RXST
Revenue
$20.3M
$32.6M
Net Profit
$-6.6M
$-9.2M
Gross Margin
17.1%
77.5%
Operating Margin
-33.9%
-34.8%
Net Margin
-32.5%
-28.1%
Revenue YoY
-51.5%
-18.9%
Net Profit YoY
17.4%
-54.1%
EPS (diluted)
$-0.12
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPR
ISPR
RXST
RXST
Q4 25
$20.3M
$32.6M
Q3 25
$30.4M
$30.3M
Q2 25
$20.1M
$33.6M
Q1 25
$26.2M
$37.9M
Q4 24
$41.8M
$40.2M
Q3 24
$39.3M
$35.3M
Q2 24
$37.3M
$34.9M
Q1 24
$30.0M
$29.5M
Net Profit
ISPR
ISPR
RXST
RXST
Q4 25
$-6.6M
$-9.2M
Q3 25
$-3.3M
$-9.8M
Q2 25
$-14.8M
$-11.8M
Q1 25
$-10.9M
$-8.2M
Q4 24
$-8.0M
$-5.9M
Q3 24
$-5.6M
$-6.3M
Q2 24
$-3.5M
$-6.1M
Q1 24
$-5.9M
$-9.1M
Gross Margin
ISPR
ISPR
RXST
RXST
Q4 25
17.1%
77.5%
Q3 25
17.0%
79.9%
Q2 25
12.3%
74.9%
Q1 25
18.2%
74.8%
Q4 24
18.5%
71.6%
Q3 24
19.5%
71.4%
Q2 24
28.3%
69.5%
Q1 24
20.4%
70.1%
Operating Margin
ISPR
ISPR
RXST
RXST
Q4 25
-33.9%
-34.8%
Q3 25
-8.9%
-40.1%
Q2 25
-72.7%
-41.6%
Q1 25
-40.4%
-28.2%
Q4 24
-17.6%
-21.5%
Q3 24
-13.4%
-26.1%
Q2 24
-9.2%
-23.9%
Q1 24
-18.8%
-36.2%
Net Margin
ISPR
ISPR
RXST
RXST
Q4 25
-32.5%
-28.1%
Q3 25
-10.7%
-32.4%
Q2 25
-73.4%
-35.0%
Q1 25
-41.5%
-21.6%
Q4 24
-19.1%
-14.8%
Q3 24
-14.2%
-17.9%
Q2 24
-9.4%
-17.4%
Q1 24
-19.7%
-30.8%
EPS (diluted)
ISPR
ISPR
RXST
RXST
Q4 25
$-0.12
$-0.22
Q3 25
$-0.06
$-0.24
Q2 25
$-0.26
$-0.29
Q1 25
$-0.19
$-0.20
Q4 24
$-0.14
$-0.14
Q3 24
$-0.10
$-0.16
Q2 24
$-0.07
$-0.16
Q1 24
$-0.11
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPR
ISPR
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$17.6M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-7.7M
$275.7M
Total Assets
$84.4M
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPR
ISPR
RXST
RXST
Q4 25
$17.6M
$228.1M
Q3 25
$22.7M
$227.5M
Q2 25
$24.4M
$227.5M
Q1 25
$23.5M
$229.3M
Q4 24
$34.4M
$237.2M
Q3 24
$37.7M
$237.1M
Q2 24
$35.1M
$233.3M
Q1 24
$39.5M
$125.4M
Stockholders' Equity
ISPR
ISPR
RXST
RXST
Q4 25
$-7.7M
$275.7M
Q3 25
$-1.8M
$276.0M
Q2 25
$604.7K
$278.0M
Q1 25
$14.8M
$279.3M
Q4 24
$24.2M
$281.2M
Q3 24
$30.7M
$277.3M
Q2 24
$34.5M
$275.2M
Q1 24
$35.9M
$163.9M
Total Assets
ISPR
ISPR
RXST
RXST
Q4 25
$84.4M
$311.8M
Q3 25
$96.4M
$308.5M
Q2 25
$102.2M
$309.0M
Q1 25
$115.7M
$313.0M
Q4 24
$132.0M
$318.6M
Q3 24
$129.0M
$310.5M
Q2 24
$122.6M
$305.5M
Q1 24
$108.0M
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPR
ISPR
RXST
RXST
Operating Cash FlowLast quarter
$-4.0M
$-1.1M
Free Cash FlowOCF − Capex
$-4.0M
$-2.3M
FCF MarginFCF / Revenue
-19.9%
-6.9%
Capex IntensityCapex / Revenue
0.3%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.2M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPR
ISPR
RXST
RXST
Q4 25
$-4.0M
$-1.1M
Q3 25
$-1.2M
$-1.2M
Q2 25
$4.7M
$-4.4M
Q1 25
$-12.5M
$-8.8M
Q4 24
$-3.2M
$-4.3M
Q3 24
$3.6M
$650.0K
Q2 24
$-1.4M
$-4.0M
Q1 24
$3.4M
$-9.3M
Free Cash Flow
ISPR
ISPR
RXST
RXST
Q4 25
$-4.0M
$-2.3M
Q3 25
$-1.2M
$-1.8M
Q2 25
$3.7M
$-5.9M
Q1 25
$-12.7M
$-9.4M
Q4 24
$-3.2M
$-5.1M
Q3 24
$3.3M
$-453.0K
Q2 24
$-2.2M
$-5.5M
Q1 24
$3.3M
$-11.3M
FCF Margin
ISPR
ISPR
RXST
RXST
Q4 25
-19.9%
-6.9%
Q3 25
-3.9%
-5.8%
Q2 25
18.6%
-17.6%
Q1 25
-48.4%
-24.8%
Q4 24
-7.7%
-12.7%
Q3 24
8.5%
-1.3%
Q2 24
-5.9%
-15.9%
Q1 24
10.9%
-38.2%
Capex Intensity
ISPR
ISPR
RXST
RXST
Q4 25
0.3%
3.5%
Q3 25
0.0%
1.9%
Q2 25
4.8%
4.6%
Q1 25
0.7%
1.5%
Q4 24
0.1%
2.1%
Q3 24
0.7%
3.1%
Q2 24
2.0%
4.4%
Q1 24
0.3%
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISPR
ISPR

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons